MetaCap

Innate Pharma S.A. (IPHA) News

NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8634-0.0765 (-8.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IPHA news summary

We found 4 recent headlines mentioning Innate Pharma S.A. (IPHA): 1 in the past week and 4 in the past 30 days, most often from Nasdaq, Business Wire. IPHA is making an outsized move today, down 8.14% at $0.8634, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Innate Pharma S.A. Presents Initial Phase 1 Clinical Data for IPH4502", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Innate Pharma S.A. headlines

Compare IPHA